News and Events

News

Daniel Harki, PhD

Daniel Harki, PhD, has been awarded the Northrop Professorship at the University of Minnesota. 

Ronald Siegel

Ron Siegel, ScD, has been named interim head of the Pharmaceutics Department, effective Feb. 17, 2020.

Valtoco nasal sprayer

Last month, VALTOCO — a nasal diazepam spray designed as a rescue therapy for patients with epilepsy who have seizure clusters — received FDA approval.

James Cloyd

James Cloyd III, PharmD, has been selected to receive the 2020 Tyler Prize for Stimulation of Research. The award recognizes an individual for encouraging research by peers, students, fellows, residents and others via publications or by directing research, serving as a preceptor, or mentoring in any discipline of the pharmaceutical sciences.

Philip Portoghese

Philip Portoghese, PhD, has been selected to receive the 2020 Research for Achievement Award in Pharmaceutical Sciences. The award recognizes and encourages outstanding meritorious achievement in any of the pharmaceutical sciences.

Ambulance and Paramedics

The University of Minnesota Twin Cities and Windgap Medical have received a $3.2 million grant from the National Institutes of Health (NIH) to develop a new device to quickly administer a recently developed antidote for cyanide poisoning.

Amy Pittenger photo

Amy Pittenger, PharmD, MS, PhD, has been named Head of the Pharmaceutical Care and Health Systems Department effective Jan. 21, 2020.

Live the #PharmLife logo

The University of Minnesota College of Pharmacy has joined with a number of other Big Ten pharmacy schools to launch Live the #PharmLife. This campaign is designed to increase awareness about the diverse and rewarding careers Big Ten pharmacy graduates enjoy. You can learn more at livethepharmlife.org.

eye

Alzheimer’s disease is the leading cause of dementia in the U.S., with approximately 5.4 million currently affected and an estimated 16 million by 2050. Damage to the brain from Alzheimer’s disease occurs years before patients exhibit symptoms. Attempted therapies have been unsuccessful largely because there is no measurable indicator — or biomarker — for Alzheimer’s disease before it is already symptomatic and advanced. 

Dr. Lisa Coles

Congratulations to Dr. Lisa Coles, along with Drs. Seaquist, Öz, Moheet, Mangia, and Eberly, on being elected to membership in the Office of Academic Clinical Affairs (OACA) Academy for Excellence in Team Science! This Academy is intended to acknowledge the valuable and significant contributions made by an exemplar interdisciplinary team conducting biomedical or health care research to address significant health challenges.

Pages

Events

Tuesday, February 25th, 2020
8:00am to 3:00pm
Friday, February 28th, 2020
9:00am to 2:30pm
Friday, May 8th, 2020
12:00pm to 2:00pm
Friday, May 8th, 2020
5:00pm to 7:00pm

Pages